Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer

被引:0
作者
Björn Nodin
Charlotta Hedner
Mathias Uhlén
Karin Jirström
机构
[1] Lund University,Department of Clinical Sciences, Division of Pathology
[2] University and Regional Laboratories Region Skåne,Department of Pathology
[3] AlbaNova University Center,Department of Proteomics, Royal Institute of Technology
[4] Royal Institute of Technology,Science for Life Laboratory
来源
Journal of Ovarian Research | / 5卷
关键词
SATB1; Immunohistochemistry; Epithelial ovarian cancer; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 139 条
[1]  
Alvarez JD(2000)The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development Genes Dev 14 521-535
[2]  
Yasui DH(2002)SATB1 targets chromatin remodelling to regulate genes over long distances Nature 419 641-645
[3]  
Niida H(2008)SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis Nature 452 187-193
[4]  
Joh T(2010)Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features APMIS 118 855-863
[5]  
Loh DY(2010)SATB1 is an independent prognostic marker for gastric cancer in a Chinese population Oncol Rep 24 981-987
[6]  
Kohwi-Shigematsu T(2012)Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer Liver international: official journal of the International Association for the Study of the Liver 32 1064-1078
[7]  
Yasui D(2012)Upregulation of SATB1 is associated with the development and progression of glioma J Transl Med 10 149-150
[8]  
Miyano M(2012)Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer Diagn Pathol 7 115-870
[9]  
Cai S(2012)Correlation of SATB1 overexpression with the progression of human rectal cancer Int J Colorectal Dis 27 143-221
[10]  
Varga-Weisz P(2012)AT-rich sequence binding protein 1: Contribution to tumor progression and metastasis of human ovarian carcinoma Oncology letters 3 865-15